Unicycive Therapeutics, Inc., (UNCY): Price and Financial Metrics

Unicycive Therapeutics, Inc., (UNCY): $0.56

0.03 (+5.34%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add UNCY to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#115 of 337

in industry

UNCY Price/Volume Stats

Current price $0.56 52-week high $1.82
Prev. close $0.53 52-week low $0.20
Day low $0.51 Volume 918,800
Day high $0.56 Avg. volume 1,092,410
50-day MA $0.67 Dividend yield N/A
200-day MA $0.58 Market Cap 58.13M

UNCY Stock Price Chart Interactive Chart >


Unicycive Therapeutics, Inc., (UNCY) Company Bio


Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.


UNCY Latest News Stream


Event/Time News Detail
Loading, please wait...

UNCY Latest Social Stream


Loading social stream, please wait...

View Full UNCY Social Stream

UNCY Price Returns

1-mo -16.42%
3-mo 21.74%
6-mo 81.23%
1-year -57.25%
3-year -58.21%
5-year N/A
YTD -29.49%
2024 -8.47%
2023 60.69%
2022 -73.79%
2021 N/A
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!